Cochrane Abstracts
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy.
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy. Accessed January 18, 2026.
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy
Anti‐vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
ID - 439791
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439791/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
